Skip to main
PTGX
PTGX logo

Protagonist Therapeutics (PTGX) Market Capitalization Overview

Market Cap: $3.35B as of Jun 18, 2025

$3.35B
Past Month+$517.55M (18.32%)
As of Jun 18, 2025, Protagonist Therapeutics (PTGX) has a market capitalization of $3.35B. Over the past 30 days, its market cap has increased by 12.55%, while in the last 12 months, it has increased by 45.28%.

Market capitalization represents the total value of Protagonist Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Protagonist Therapeutics (PTGX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Protagonist Therapeutics (PTGX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Protagonist Therapeutics (PTGX) Market Cap History

DateMarket CapChange
Jun 2, 2025$3.11B+12.55%
May 1, 2025$2.77B-4.03%
Apr 1, 2025$2.88B+21.77%
Mar 3, 2025$2.37B+6.60%
Feb 3, 2025$2.22B-4.57%
Jan 2, 2025$2.33B-9.89%

Protagonist Therapeutics (PTGX) End of Year Market Cap History

DateMarket CapChange
2025$3.35B+45.28%
2024$2.31B+73.94%
2023$1.33B+146.40%
2022$536.76M-67.12%
2021$1.64B+92.43%
2020$848.27M

FAQs About Protagonist Therapeutics (PTGX) Market Cap

As of Jun 18, 2025, the market capitalization of Protagonist Therapeutics (PTGX) is $3.35B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Protagonist Therapeutics’s market capitalization has increased by 18.32%, changing from $2.83B to $3.35B as of Jun 18, 2025.

In the last 3 months, Protagonist Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Protagonist Therapeutics’s market capitalization increased from $1.33B in January to $2.31B in December, reflecting a 73.94% change.

In the past five years, Protagonist Therapeutics (PTGX) has had a compound annual growth rate (CAGR) of 22.08% in market capitalization. This means its market cap has grown at an average rate of 22.08% per year.

Protagonist Therapeutics (PTGX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.